Cargando…
Immune checkpoint inhibitors: the new frontier in non-small-cell lung cancer treatment
Lung cancer is the major cause for cancer-related death in the US. Although advances in chemotherapy and targeted therapy have improved the outcome of metastatic non-small-cell lung cancer, its prognosis remains dismal. A deeper understanding of the complex interaction between the immune system and...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4993420/ https://www.ncbi.nlm.nih.gov/pubmed/27574451 http://dx.doi.org/10.2147/OTT.S111209 |